VANFLYTA 26.5 mg film-coated tablets
*Company:
Daiichi Sankyo Ireland LtdStatus:
No Recent UpdateLegal Category:
Product subject to medical prescription which may be renewed (B)Active Ingredient(s):
This medicinal product is subject to additional monitoring.
*Additional information is available within the SPC or upon request to the company
Educational materials 'FOR HEALTHCARE PROFESSIONALS' (HCPs) are additional risk minimisation measures that are intended to promote the safe and effective use of the medicinal product.
(Click to Download) VANFLYTA - Patient Card
Risk Minimisation Materials
(Click to Download) VANFLYTA - Health Care Professional Guide - Serious risks associated with Vanflyta
Risk Minimisation Materials
Daiichi Sankyo Ireland Ltd
Address:
Unit 29, Block 3, Northwood Court, Northwood Avenue, Santry, Dublin 9, IrelandMedical Information E-mail:
medinfo@daiichi-sankyo.ieTelephone:
+353 1 489 3000Fax:
+353 1 489 3033